Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2021-03-30

Clinical Trial Update: Trichloroacetic Acid (TCA) Combined With Microdermabrasion in Treatment of Melasma [Phase 4]

View source ↗

Summary

Clinical trial update for a Phase 4 study evaluating trichloroacetic acid (TCA) combined with microdermabrasion in treating melasma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Trichloroacetic acid (TCA) + microdermabrasion (trichloroacetic acid (TCA) with microdermabrasion)

Snippet

Sponsor: Assiut University | Conditions: Melasma | Phase 4 | Status: UNKNOWN